A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy

Cephalalgia

Volumn 34, Issue 1, 2014, Pages 68-72

  Costa, Cinzia ^a,b   Prontera, Paolo ^a,c   Sarchielli, Paola ^a   Tonelli, Alessandra ^d   Bassi, Maria Teresa ^d   Cupini, Letizia Maria ^e   Caproni, Stefano ^a   Siliquini, Sabrina ^a   Donti, Emilio ^c   Calabresi, Paolo ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c Ospedale S Maria della Misericordia   (Italy)

^d SCIENTIFIC INSTITUTE   (Italy)

^e S EUGENIO HOSPITAL   (Italy)

Author keywords

ATP1A2 gene; epilepsy; FHM2; GEFS+; migraine

Indexed keywords

ADENINE; ATP1A2 PROTEIN; CARRIER PROTEIN; GUANINE; PHENOBARBITAL; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARM WEAKNESS; ARTICLE; BRAIN CONCUSSION; CLINICAL ARTICLE; COMORBIDITY; COMPLEX PARTIAL SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; ECHOGRAPHY; EXON; FAMILIAL HEMIPLEGIC MIGRAINE; FEBRILE CONVULSION; FEMALE; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC ANALYSIS; HEAD INJURY; HEADACHE; HUMAN; LIMB WEAKNESS; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SPEECH DISORDER; TRANSIENT ISCHEMIC ATTACK; VISUAL IMPAIRMENT; VOMITING;

ATP1A2 GENE; EPILEPSY; FHM2; GEFS+; MIGRAINE;

ADULT; AGED; EPILEPSY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMIPLEGIA; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84890835702     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102413498941     Document Type: Article

References (12)

1. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol. 2006 ; 5: 148-157 (Pubitemid 43107850)
2. Vanmolkot KR, Kors EE, Hottenga JJ, et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol. 2003 ; 54: 360-366 (Pubitemid 37072038)
3. Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol. 2008 ; 65: 709-714 (Pubitemid 351831448)
4. Parisi P, Piccioli M, Villa MP, et al. Hypothesis on neurophysiopathological mechanisms linking epilepsy and headache. Med Hypotheses. 2008 ; 70: 1150-1154
5. Deprez L, Weckhuysen S, Peeters K, et al. Epilepsy as part of the phenotype associated with ATP1A2 mutations. Epilepsia. 2008 ; 49: 500-508 (Pubitemid 351294535)
6. Pierelli F, Grieco GS, Pauri F, et al. A novel ATP1A2 mutation in a family with FHM type II. Cephalalgia. 2006 ; 26: 324-328
7. Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: Pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011 ; 10: 457-470
8. Lutsenko S, Kaplan JH. An essential role for the extracellular domain of the Na,K-ATPase β-subunit in cation occlusion. Biochemistry. 1993 ; 32: 6737-6743 (Pubitemid 23217145)
9. Sadleir LG, Scheffer IE. Febrile seizures. BMJ. 2007 ; 334: 307-311 (Pubitemid 46293967)
10. Nakayama J. Progress in searching for the febrile seizure susceptibility genes. Brain Dev. 2009 ; 5: 359-365
11. Wallace RH, Scheffer IE, Barnett S, et al. Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2001 ; 68: 859-865 (Pubitemid 32289731)
12. Fujiwara T. Clinical spectrum of mutations in SCN1A gene: Severe myoclonic epilepsy in infancy and related epilepsies. Epilepsy Res. 2006 ; 70S1: S223 - S230